2023 women's health outlook

Eliminating a modest out-of-pocket cost significantly increased digital breast tomosynthesis use and reduced disparities across racial, ethnic, and language groups.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals rising breast cancer rates among minority women aged 65 to 74 years, highlighting the need for targeted screening and intervention strategies.

Oral sulopenem (ORLYNVAH; Iterum Therapeutics) was non-inferior to amoxicillin/clavulanate for treating uUTIs in women, per the phase 3 REASSURE trial.

New research shows women receiving Medicaid and support services are significantly more likely to receive treatment for opioid and drug use disorders.